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Neuronal hemoglobin affects dopaminergic cells’
response to stress
Marta Codrich1,2, Maria Bertuzzi1, Roberta Russo1, Margherita Francescatto3, Stefano Espinoza3, Lorena Zentilin4, Mauro Giacca4,
Daniela Cesselli5, Antonio Paolo Beltrami5, Paolo Ascenzi6, Silvia Zucchelli1,2, Francesca Persichetti2, Giampiero Leanza7 and
Stefano Gustincich*,1,3
Hemoglobin (Hb) is the major protein in erythrocytes and carries oxygen (O2) throughout the body. Recently, Hb has been found
synthesized in atypical sites, including the brain. Hb is highly expressed in A9 dopaminergic (DA) neurons of the substantia nigra
(SN), whose selective degeneration leads to Parkinson’s disease (PD). Here we show that Hb confers DA cells’ susceptibility to
1-methyl-4-phenylpyridinium (MPP+) and rotenone, neurochemical cellular models of PD. The toxic property of Hb does not depend
on O2 binding and is associated with insoluble aggregate formation in the nucleolus. Neurochemical stress induces epigenetic
modifications, nucleolar alterations and autophagy inhibition that depend on Hb expression. When adeno-associated viruses
carrying α- and β-chains of Hb are stereotaxically injected into mouse SN, Hb forms aggregates and causes motor learning
impairment. These results position Hb as a potential player in DA cells’ homeostasis and dysfunction in PD.
Cell Death and Disease (2017) 8, e2538; doi:10.1038/cddis.2016.458; published online 5 January 2017
Parkinson’s disease (PD) is a chronic progressive neurode-
generative disorder clinically defined in terms of motor
symptoms. The most evident pathological hallmarks are the
selective degeneration of A9 dopaminergic (DA) neurons of
substantia nigra pars compacta (SNpc) and the presence of
intracellular aggregates called Lewy bodies. The consequent
loss of DA synapses in the striatum is the primary origin of the
inability to control movements.1 The causes of the selective
degeneration of A9 neurons remain unknown.2
The identification of genes involved in early-onset PD has
proved the crucial role of mitochondria,1 of the ubiquitin-
proteasome system1 and autophagy.3
Epidemiological data showed that rural areas with heavy
use of pesticides present a higher incidence of PD.4 The
insecticide rotenone and the neurotoxin precursor 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP) have been exten-
sively used as PD-mimicking models to study the molecular
mechanisms of DA cells’ degeneration.5,6 Both of them
provoke depletion of intracellular ATP intervening on the
homeostasis of mitochondrial activity and autophagy.7–9
In this context, the structure and function of the nucleolus
have been found altered in post mortem PD brains. A correct
ribosome biogenesis is essential to the survival of DA neurons
in vivo10 while nucleolar damage is present in mouse DA cells
upon MPTP intoxication.11
In the quests for the molecular basis of DA cells’dysfunction
in PD, interesting cues have been obtained by comparing the
molecular constituents of A9 DA cells of the SN with those of
the adjacent A10 DA neurons of the ventral tegmental area.
As these cells do not degenerate in PD, differential gene
expression analysis has been associated with A9 suscept-
ibility in disease. Examination of gene categories has high-
lighted that genes encoding energy-related metabolism,
electron transport and mitochondria proteins appear to be
more expressed in A9 rather than A10 neurons.2
We and others have previously identified the transcripts of α- and
β-chains of hemoglobin (Hb) in A9 DA neurons.12,13 Hb immunor-
eactivity decorates the large majority of the nucleus and cytoplasm
of A9cells, whereas it stains onlyo5%ofA10neuronsproving that
Hb is differentially expressed in the DA cells’ groups. In the
mesencephalon, Hb retains its tetrameric structure as in blood.14
The function of Hb in DA neurons remains unclear. We have
previously shown that its overexpression in a mouse DA cell
line was altering transcript levels of genes involved in oxygen
(O2) homeostasis and oxidative phosphorylation.
12
In this study, we provide evidence that neuronal Hb may
contribute to DA cells’ dysfunction in PD by interfering with
pathways involved in neurodegeneration.
Results
Hb increases susceptibility to cell death in cellular
models of PD. To investigate the role of Hb in PD, we
analysed the effects of Hb overexpression upon
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PD-mimicking insults. We took advantage of the DA cell line
iMN9D whose differentiation can be triggered by an inducible
artificial system to increase the expression of Nurr1, a
transcription factor involved in DA cells’ differentiation and
maintenance. These cells overexpress stably α- and β-chains
of Hb forming the α2β2 tetramer.
12,14
Differentiated cells were treated with increasing concentra-
tions of 1-methyl-4-phenylpyridinium (MPP+), the active ion of the
neurotoxin MPTP, or of the pesticide rotenone. Both molecules
induce mitochondrial dysfunction leading to caspase activation
and cell death.1,8 Upon their administration, we analysed the
levels of cleaved Caspase-3, a marker of apoptosis, through
western blotting. We then tested cell mortality with FACS and
monitored the metabolic activity of viable cells with WST-1.
First, we focussed our attention on differentiated cells
treated with MPP+. Twenty-four hours after plating, doxycy-
cline was supplemented to induce Nurr1 expression and DA
cells’ differentiation. MPP+ was added 56 h later when cells
were approximately 80% confluent. After additional 16 h, cells
were collected and analysed. We used MPP+ at the
concentrations of 0.1, 0.2, 0.5 or 1 mM. Levels of cleaved
Caspase-3 were higher in Hb cells than controls in a dose-
dependentmanner (Figure 1a). Densitometric quantification of
pro-Caspase-3 and cleaved Caspase-3 are shown in
Supplementary Figures S1a and c. FACS analysis demon-
strated that cell death wasmore evident in Hb cells upon 1 mM
MPP+ addition (Figure 1b). WST-1 assay showed that Hb cells
exhibited about 20% less viability in comparison to controls
upon MPP+ treatment (Figure 1c).
We then analysed the effects of rotenone in the same
experimental settings. We used rotenone at the
concentrations of 1, 10, 50 or 100 μM. A higher level of
cleaved Caspase-3 was evident in Hb cells when compared
with controls upon rotenone treatment in a dose-dependent
manner (Figure 1d). Densitometric quantification of pro-
Caspase-3 and cleaved Caspase-3 are shown in
Supplementary Figures S1b and d. FACS analysis showed a
higher death ratio in Hb cells upon drug treatments (Figure 1e).
WST-1 assay proved Hb cells presented about 30% less
viability in comparison to controls upon rotenone administra-
tion (Figure 1f).
To assess whether Hb toxicity is O2 dependent, we
generated a stable cell line overexpressing a mutant Hb
(mut Hb) that is unable to bind O2. In detail, we mutated the
proximal histidine residue (F8) of both α- and β-chains to
glycine. This small residue does not allow the fifth coordination
bond of the heme-Fe atom.15,16 Once mutated, Hb cells were
generated (Supplementary Figures S2a and b), differentiated
and their mortality compared with Hb cells and controls
upon PD-mimicking insults. As shown in Supplementary
Figure S2c, mut Hb cells did not prevent Hb toxicity. Although
there was slightly less cleaved Caspase-3 in mut Hb cells in
comparison to Hb cells, we interpreted it as owing to lower Hb
level in mut Hb cells (Supplementary Figure S2a).
These experiments indicate that Hb overexpression
increases susceptibility to cell death in cellular models of PD
with mechanisms that do not depend on O2 binding.
Neurochemical intoxication increases Hb in the nucleus.
We performed cellular fractionation experiments to study the
intracellular distribution of Hb upon PD-mimicking insults. In
untreated conditions, α- and β-chains were present both in
Figure 1 Hb increases susceptibility to cell death in cellular model of PD. Differentiated Hb cells (Hb) and control cells (control) were treated with MPP+ (a–c) or rotenone
(d–f) at the indicated concentrations for 16 h. (a and d) Western blotting analysis of cleaved Caspase-3 (cleaved Casp3) expression. α- and β-Globins were detected with anti-
FLAG and anti-MYC antibodies, respectively. For normalization, the levels of pro-Caspase-3 (pro-Casp3) were detected. β-Actin was used as a loading control. (n= 3, n= 3)
(b and e) FACS analysis. Percentage of subG1 cells is expressed as fold increased relative to untreated cells, arbitrary set to 1. (n= 3, n= 4) (c and f) WST-1 analysis. In graph
are represented the percentage of viable cells relative to untreated cells, arbitrary set to 100%. (n= 4, n= 3) Values are mean± S.D. Data were evaluated statistically by
Student’s t-test. Resulting P-values are indicated (NS= not significant)
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the cytoplasm and in the nucleus of differentiated iMN9Dcells
(Figures 2a–d). Upon MPP+ and rotenone treatments, the
levels of α-globin (visualized with anti-FLAG antibody) and β-
globin (visualized with anti-MYC antibody) increased in the
nucleus (Figures 2a and c). Interestingly, an α-globin band of
about 20 kDa appeared in the nucleus, unveiling posttransla-
tional modifications of the α-chain potentially associated with
toxicity. Densitometric quantification of nuclear FLAG (α-
globin) and MYC (β-globin) are shown in Supplementary
Figures S1e–h. Mutated α-globin accumulated in the nucleus
upon rotenone treatment as reported for wild-type Hb,
indicating again that Hb-mediated toxic mechanisms do
not require O2 binding (Supplementary Figure S2d). These
results were confirmed with immunofluorescence (Figures 2b
and d).
Importantly, α- and β-chains assembly was not altered upon
toxic stimuli (Supplementary Figures S3a and b).
These data prove that in differentiated Hb cells the exposure
to MPP+ and rotenone increases the amount of Hb in the
nucleus and the fraction of a nuclear Hb form modified at
posttranslational level.
Hb modifies the epigenetic status of DA neurons under
stress. As MPTP and rotenone have been previously shown
to affect the epigenome of neurons,17,18 we analysed H3
methylation status in our experimental settings (Figure 2e).
The level of H3 lysine 9 dimethylation (H3K9me2) was
reduced in Hb cells in comparison to control cells in untreated
conditions, while treated Hb cells presented 27% less H3
lysine 4 trimethylation (H3K4me3) than controls (Figure 2f). It
Figure 2 Neurochemical intoxication increases Hb in the nucleus. Differentiated Hb cells were treated with MPP+ (a and b) or rotenone (c–f) at the indicated concentrations
for 16 h. (a and c) Western blotting analysis of cellular fractionation was carried out with anti-FLAG (α-globin) and anti-MYC (β-globin) antibodies. Anti-TH and anti-UBF
antibodies were used to visualize specifically cytoplasm and nucleus compartment, respectively. β-Actin was used as a loading control. (n= 5, n= 4) (b and d) Double
immunofluorescence was performed with anti-FLAG (α-globin) and anti-MYC (β-globin) antibodies. Nuclei were marked by DAPI (4,6-diamidino-2-phenylindole). Scale bar 5 μm.
(n= 3, n= 4) (e) Western blotting analysis of H3K4me3 and H3K9me2 expression. For normalization, the total levels of H3 and β-actin were detected. Levels of pro-Caspase-3
(pro-Casp3) and cleaved Caspase-3 (cleaved Casp3) were also monitored. (n= 3) (f) Densitometric analysis of H3K4me3 and H3K9me2 expression. H3K4me3 and H3K9me2
levels were normalized to H3 and β-actin. Untreated control cells was used as reference and set to 100%. (n= 3, n= 3) Values are mean±S.D. Data were evaluated statistically
by Student’s t-test. The P-values were adjusted for multiple testing using the Benjamini–Hochberg method to control the false discovery rate. Resulting P-values are indicated
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is well known that the H3K4me3 signature is correlated with
transcription activation.19,20 Among the validated targets,
high levels of H3K4me3 at promoter and coding regions of
the p53 gene are known to facilitate p53 transcription.21 By
taking advantage of qRT-PCR analysis in Hb and control
cells, a correlation was showed between H4K4me3 and p53
mRNA levels (Supplementary Figure S3c).
These data prove that Hb can regulate the epigenome of
neurons upon stress and in untreated conditions.
Neurochemical intoxication accumulates insoluble Hb in
the nucleolus. As the formation of insoluble aggregates is a
hallmark of PD, we tested the solubility of Hb in our
experimental preparation. Figures 3a and b shows that upon
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treatments with MPP+ and rotenone α-chain accumulated in
the insoluble portion while in untreated conditions globin
chains were mainly, but not exclusively, localized in Triton
X-100 soluble fractions. Furthermore, the quantification
analysis of insoluble FLAG (α-globin)-positive bands demon-
strates that there is an increase of the 17 and 20 kDa bands
upon treatments (Figure 3c). Immunofluorescence analysis
was then carried out after permeabilization with Triton X-100
before fixation. Although a small amount of α- and β-globin-
containing aggregates were already present in untreated
cells, PD-mimicking insults strongly induced Hb aggregation
(Figures 3d and f) mainly in the nucleus. The quantification of
Hb insoluble aggregates are shown in Figures 3e and g.
Double immunofluorescence for α-globins (visualized with
anti-FLAG antibody) and Nucleophosmin (NPM), a specific
marker for granular component of the nucleolus, proved that
Hb aggregates were contained within nucleolar structures
(Figures 3h and i).
These data demonstrate that PD-mimicking insults increase
nucleolar aggregation of Hb.
Hb induces nucleolar stress. Given the presence of Hb
aggregates in the nucleoli, we assessed the synthesis of pre-
rRNA transcripts as a marker of nucleolar stress. Figure 4a
shows that Hb overexpression inhibited rRNA biogenesis in
untreated cells. Importantly, PD-mimicking insult decreased
pre-rRNA transcripts levels both in Hb cells and controls
although with a statistically significant stronger effect on
Hb cells.
These data indicate that Hb overexpression increases
nucleolar stress affecting rRNA biosynthesis.
Hb impairs autophagy induced by neurochemical insults.
Autophagy is a crucial homeostatic response of DA cells to
neurochemical intoxication and its pharmacological induction
with rapamycin protects cellular and animal models of PD.8,9
To investigate the effects of Hb overexpression, we monitored
the phosphorylation status of the eukaryotic initiation factor
4E binding protein 1 (4E-BP1), a direct target of mTOR,22
showing that in Hb cells the phosphorylation of 4E-BP1 was
stable while reduced in control cells, as expected (Figure 4b).
These results indicate that Hb expression inhibits down-
regulation of mTOR activity by rotenone treatment. Densito-
metric quantification of P-4EB-P1 is shown in Supplementary
Figure S1l.
We then monitored the induction of LC3II as a marker of
autophagosome formation and therefore of autophagic activ-
ity. Although rotenone treatment triggered increased levels of
LC3II in control cells, in Hb cells it failed to do so (Figure 4b).
Densitometric quantification of LC3II is shown in
Supplementary Figure S1m. To further assess the impact of
Hb on autophagy, neurons were stained with LysoTracker Red
(Figure 4c), which labels acidic organelles, including autop-
hagosomes in living cells. Upon rotenone treatment, the
quantification of LysoTracker Red-positive foci per cell
demonstrated in Hb cells the inhibition of the prominent rise
of autophagosome density observed in controls (Figure 4d).
These data demonstrate that Hb overexpression is asso-
ciated with an impairment of autophagy induction by preser-
ving mTOR activity.
AAV9-mediated delivery of Hb in SNpc inhibits improve-
ment of motor performance and triggers Hb aggregates
in DA cells. To assess the role of Hb in DA neurons in vivo,
we overexpressed Hb in SNpc of mouse brain. Eight-week-
old male C57Bl/6 mice were injected with a mixture of AAV9-
2xFLAG-α-globin and AAV9-β-globin-MYC (indicated as
AAV9-Hb) or with AAV9-control into SNpc of mouse brain.
The contralateral SNpc remained uninjected. Supplementary
Figure S4 shows the characterization of AAV9 vector
injection in SNpc of mouse brain. Double immunofluores-
cence for Hb and the specific DA marker tyrosine hydroxylase
(TH) revealed that AAV9 vectors were efficiently transduced
in DA neurons in the ipsilateral side (Supplementary Figures
S4d and e). Furthermore, double immunofluorescence for
tagged α- and β-globin demonstrated their co-localization in
DA cells, confirming the efficiency of co-infection
(Supplementary Figure S4g).
To determine Hb overexpression effects on DA neurons, we
monitored mice motor coordination using rotarod test. We
assayed AAV9-Hb and AAV9-control mice at the indicated
weeks (Figure 5a). Data in Figure 5b show the mice latency,
defined as the amount of time the mice stayed on the rotating
rod at different r.p.m. No differences were observed in
performance between AAV9-Hb and AAV9-control mice at
all four speeds before AAV9 vector injection. During the time of
the experiment, there was no group difference in performance
at 5 and 10 r.p.m. Strikingly, when the difficulty of the test was
increased (15 r.p.m.) we observed a statistical difference
between AAV9-Hb- and AAV9-control-injected mice unveiling
changes in locomotor activity that increased with time:
AAV9-Hb (I) 123±25, (II) 91±18, (III) 112± 20; AAV9-
control (I) 148± 21, (II) 157± 22, (III) 200± 23. Although
AAV9-control mice improved their performance, AAV9-Hb
mice failed to do so. Finally, both groups had an unsuitable
performance at 20 r.p.m.
Figure 3 Neurochemical intoxication accumulates insoluble Hb in the nucleolus. Differentiated Hb cells were treated with MPP+ (a, d, h) or rotenone (b, f, i) at the indicated
concentrations for 16 h. (a and b) Western blotting analysis of soluble and insoluble fractionation was carried out with anti-FLAG (α-globin) and anti-MYC (β-globin) antibodies. α-
Tubulin was used to visualize specifically soluble fraction. β-Actin was used as a loading control. (FLAG n= 3, MYC n= 2; FLAG n= 4, MYC n= 2) (c) Densitometric analysis of
insoluble FLAG (α-globin) level. Insoluble α-globin level was normalized to β-actin. Untreated cells was used as reference and set to 100%. (n= 3, n= 3) (d and f) Solubilized
double immunofluorescence was performed with anti-FLAG (α-globin) and anti-MYC (β-globin) antibodies. Nuclei were marked by DAPI (4,6-diamidino-2-phenylindole). Scale
bar 5 μm. (n= 3, n= 3) (e and g) Quantification of globin chain aggregates in the cells. An average of 120 randomly chosen cells were counted for quantification of each
condition. Values are expresses as a percentage relative to the total. (h and i) Solubilized double immunofluorescence was performed with anti-FLAG (α-globin) and anti-NPM
antibodies. Nuclei were marked by DAPI. Scale bar 5 μm. (n= 2, n= 2) Values are mean± S.D. Data were evaluated statistically by Student’s t-test. Resulting P-values are
indicated
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These data demonstrate that AAV9-mediated Hb expres-
sion in SNpc inhibits improvement in performance associated
with motor learning. Recent evidence suggests that DA
neurotrasmission is linked to cognitive function, in particular
DA depletion impairs motor learning.23 Consequently, we
performed HPLC on differentiated Hb and control cells to
measure DA content. As shown in Supplementary Figure S5,
DA level is significantly reduced by about 50% in Hb cells in
comparison to controls.
Four weeks after AAV9 vector injection, micewere killed and
brain tissues were processed for immunohistochemical
analysis. We first performed a densitometric analysis of TH+
fibres in the striatum, direct target of DA innervation from the
SN. We observed that Hb overexpression did not alter TH+
fibres comparing AAV9-Hb and AAV9-control mice (Figures 5c
and e). We then quantified DA neurons counting A9 cells in
SNpcwith a computer-assisted stereological assessment tool.
We first proved that the injection itself did not cause damage,
as the number of TH+ cells in the ipsilateral and
contralateral sides of AAV9-control mice were equal
(Figures 5d and f). We then showed that the total number
of DA neurons was not altered by Hb overexpression.
Interestingly, Hb-overexpressing TH+ cells presented
cytoplasmic and nuclear α-globin aggregates (Figure 5g).
The majority of these structures were immunoreactive for both
tagged-globin proteins (Figure 5h).
These data suggest that Hb overexpression does not alter
DA cells’ anatomy but triggers aggregate formation in TH+
neurons.
Discussion
Globins are present in all kingdoms of living organisms where
they display a variety of functions, including O2 sensing,
Figure 4 Hb induces nucleolar stress and impairs autophagy in cellular model of PD. Differentiated Hb cells (Hb) and control cells (control) were treated with rotenone at the
indicated concentrations for 16 h. (a) qRT-PCR of pre-rRNA levels. Pre-rRNA levels were normalized to β-actin. Untreated control cells was used as reference and set to 1. (n= 5)
(b) Western blotting analysis of phosphorylated 4E-BP1 (P-4E-BP1) status and LC3 expression. For normalization, the total levels of 4E-BP1 were detected. Levels of pro-
Caspase-3 (pro-Casp3) and cleaved Caspase-3 (cleaved Casp3) were also monitored. β-Actin was used as a loading control. (n= 5) (c) LysoTracker Red staining. Nuclei were
marked by DAPI (4,6-diamidino-2-phenylindole). Scale bar 10 μm. (n= 3) (d) Quantification of autophagosome. Ninety randomly chosen cells were counted for quantification of
each condition. Values are expressed as a percentage relative to the total. Autophagy activity was defined as follows: high: 410 LysoTracker Red foci/cell; medium: 6–10
LysoTracker Red foci/cell; low:o6 LysoTracker Red foci/cell. Values are mean± S.D. Data were evaluated statistically by Student’s t-test. The P-values were adjusted for multiple
testing using the Benjamini–Hochberg method to control the false discovery rate. Resulting P-values are indicated (NS= not significant)
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transport and storage, the synthesis and scavenging of
reactive nitrogen and oxygen species and heme-based
catalysis.24 In the past decade, Hb α- and β-chains have been
found expressed in a plethora of nonerythroid cells.24
Several reports have shown regulated expression of α- and
β-chain transcripts as well as Hb immunoreactivity in the
mammalian brain, including in neurons of themesencephalon,
cortex (CTX) and hippocampus13,25–27 as well as in oligoden-
drocytes and selective astrocytes.12,28
Recent evidences suggest the involvement of Hb in
neurodegenerative diseases. First, an increase of Hb expres-
sion has been observed in neurons of aging brains in rodents
Figure 5 AAV9-mediated delivery of Hb in SNpc inhibits improvement of motor performance and triggers Hb aggregates in DA cells. (a) Scheme of experimental settings.
(b) Latency in rotarod test in AAV9-control (n= 18) and AAV9-Hb (n= 19) mice at 5, 10, 15 and 20 r.p.m. (c) Immunohistochemistry of coronal sections of AAV9-control and
AAV9-Hb mouse brain. TH+ fibres in the striatum were stained with anti-TH antibody. Scale bar 800 μm. (d) Immunohistochemistry of coronal sections of AAV9-Hb and
AAV9-control mouse brain. SN was stained with anti-TH antibody. Scale bar 200 μm. (e) Densitometric analysis of TH+ fibres in AAV9-Hb (n= 18) and AAV9-control (n= 18)
mice. Values are expresses as a percentage relative to the contralateral side of AAV9-control mice, arbitrary set to 100%. (f) Quantitative analysis of TH+ cells number in AAV9-Hb
(n= 16) and AAV9-control (n= 15) mice. Values are expressed as the number of total TH+ cells relative to the contralateral side of AAV9-control mice. (g) Immunohistochemistry
of coronal sections of AAV9-Hb mouse brain. SN was stained with anti-TH antibody. Infected cells were stained with anti-FLAG (α-globin) antibody. Arrow indicates α-globin
aggregates. Nuclei were visualized with DAPI (4,6-diamidino-2-phenylindole). Scale bar 50 μm. (h) Immunohistochemistry of coronal sections of AAV9-Hb mouse brain. SN was
stained with anti-TH antibody. Infected cells were stained with anti-FLAG (α-globin) and anti-MYC (β-globin) antibodies. Arrow indicates globin aggregates. Scale bar 10 μm. All
data are represented as mean±S.E.M. Data were evaluated statistically by one-way analysis of variance. Resulting P-values are indicated
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and human.29,30 Hb was found highly expressed in the
neurons and glia in Alzheimer’s disease (AD) brains, in APP/
PS1 transgenic AD mice models and in the cerebrospinal fluid
of AD patients.30 Hb co-localized with senile plaques and
vascular amyloid deposits in AD while α- and β-chains were
shown to interact with Aβ oligomer in AD brain homogenates
promoting Aβ oligomer formation.30 These results have led to
the intriguing hypothesis that Hbmay have an important role in
the association between cerebral vascular diseases and AD.31
Transcriptome profiling showed that α- and β-globins were
the twomost induced transcripts in the white matter of patients
suffering from multiple system atrophy.32 By contrast, they
were the two most downregulated transcripts in the brains
from bovine spongiform encephalopathy-infected cynomolgus
macaques, a model for human prion disorders.33
Several intriguing observations suggest Hb as a potential
player in PD.34 Its distribution in mesencephalic DA neurons
enlists Hb into the small number of genes whose expression
correlates with cells’ vulnerability.2,12 α- and β-Chains mRNAs
were found strongly downregulated in DA neurons of rats
treated with low doses of rotenone.35 Intriguingly, they were
upregulated in post mortem PD brains.36 Furthermore, Hb and
α-synuclein complex was recently found in brain tissue and red
blood cells of aging cynomolgus monkeys.37
We previously showed that overexpression of α- and
β-chains in iMN9D cells altered the expression of genes
involved in mitochondrial activity.12 Since then, Hb has been
found accumulated in the mitochondria of human SN neurons
and frontal CTX cells from post mortem PD brains.38,39 Here
we have demonstrated that Hb overexpression increases
susceptibility to cell death in differentiated iMN9D cells
exposed to MPP+ and rotenone. Both drugs are known to
inhibit complex I of the mitochondrial electron transport chain
provoking a decrease of the ATP reserve.7 Interestingly, Hb
accumulates in the mitochondria of post mortem brain tissues
of other diseases such as multiple sclerosis (MS), where it
interacts with several mitochondrial proteins, including ATP
synthase subunits.40
In this context, here we show for the first time that Hb is able
to interfere with pathways crucial to PD pathogenesis such as
DA content, nucleolar function, autophagy and epigenetic
remodelling. Importantly, Hb forms insoluble aggregates in DA
neurons in vitro and in vivo. Although the majority of these
phenotypes are already present in untreated cells, they are
strongly induced upon neurochemical intoxication.
The formation of detergent-insoluble aggregates is con-
sidered one of the hallmarks of PD. Hb aggregates are
induced by neurochemical intoxication in vitro and they
accumulate upon α- and β-chain overexpression in DA
neurons of the SN in vivo. Aggregates are formed prevalently
in the nucleolus and are associated with a posttranslational
modification of the α-chain present in the insoluble fraction.
Further work is needed to assess its identity and role in Hb
toxicity.
Hb aggregates are localized in the nucleoli in vitro. Themain
function of the nucleolus is to coordinate ribosome biogenesis
although it is increasingly evident that it acts as a response
centre to various insults, including oxidative and proteotoxic
stresses.41 Nucleoli have been found essential to the survival
of DA neurons in vivo11 while their structure and function are
altered in post mortemPD brains.42,43 Interestingly, neurotoxic
stimuli inhibited rRNA synthesis and impaired rRNA
biogenesis.11 In this study, we show that Hb overexpression
decreases pre-rRNA transcription inducing nucleolar stress
upon intoxication and in untreated conditions. Although in the
short-term this is considered a defence mechanism to limit
energy squander preserving cell survival, protracted down-
regulation of rRNA transcription results in severe cellular
damage and cell death.44 In this context, it has been recently
demonstrated that the ablation of the RNA polymerase
I-specific transcription initiation factor IA causes disruption of
nucleoli and a transient pro-survival response, involving the
inhibition of mTOR signaling and the activation of autophagy.45
Dysregulation of the autophagic pathway has been
observed in human post mortem PD brains and in animal
models while genes mutated in familial PD are involved in its
regulation.46 Importantly, autophagy enhanced by rapamycin
protects against cell death caused by MPTP and rotenone.8,47
An intriguing relationship may thus be hypothesized between
Hb toxicity and its ability to inhibit mTOR impairing autophagy.
The role of epigenetics in PD is under intense scrutiny.
Dopamine depletion is associated with a reduction in histone
H3K4me3, whereas treatment with MPTP and rotenone
induces H3 acetylation.18,48 The expression of epigenetic
modifiers is dysregulated in the blood of living PD patients.18
Interestingly, β-globin interacts with H3 and histone lysine
demethylase in postmortemMSCTX,40 suggesting that it may
regulate H3 methylation status. It is therefore intriguing that
upon PD-mimicking insults we observed an increase of Hb in
the nucleus and a concomitant decrease of H3K4me3.
We then studied the effects of Hb overexpression in vivo.
Two striking phenotypeswere observed in the timeframe of the
experiment (1 month). As in vitro, aggregates are present in
the nucleus of TH+ cells. In the large majority of cases, they
contain both α- and β-chains. Most importantly, we observed a
significant difference in motor behaviour between AAV9-Hb
mice and AAV9-controls. To our knowledge, this is the first
experimental evidence of behavioural effects of neuronal Hb.
As it is well known that changes in DA neurotransmission
result in motor skill learning deficit23 and that we observed a
reduction of DA content owing to Hb overexpression, we
speculate that Hbmay influence the physiological status of DA
neurons leading to a dysregulation of DA neurotransmission.
No changes in DA histology were found considering densito-
metric analysis of TH+ fibres in the striatum and the number of
total TH+ neurons in SN. Although genetic inhibition of rRNA
biogenesis requires several months to trigger DA cells’
degeneration, AAV9-Hb mice with motor skill learning deficit
were analysed 1 month upon AAVs injection, opening the
possibility that neuronal damage may become evident at
later time.
Although our data prove that neuronal Hb regulates path-
ways involved in PD pathogenesis and potentially DA activity
in vivo, its function remains unclear. By replacing the highly
conserved proximal histidine F8 residue with a glycine,
mutated Hb presents a low affinity for the heme group and a
loss of its allosteric properties.15,16 In these conditions, we
observed that mutated Hb confers susceptibility to neurotoxic
stimuli as wild-type Hb, suggesting that Hb toxicity does not
depend on O2 binding.
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Overall, we hypothesize that neuronal Hb acts as a sensor
of the energy status of neurons. By linking ATP concentration
and mitochondrial function to mTOR activity, it may regulate
cells’ stress response acting on ribosome biogenesis,
autophagy, the epigenome and, ultimately, DA cells’
neurotransmission.
Although it is unclear how Hb expression is regulated in
nonerythroid cells, A9 neurons present the expression of
GATA family members12,49 that are the major Hb transcrip-
tional regulators. In this context, any environmental or genetic
conditions that modify Hb levels in A9 cellsmay affect neuronal
susceptibility. Interestingly, Hb chains have been found highly
induced by low iron diet in the ventral midbrain of adult mice,
implicating them in brain iron homeostasis, a pathway involved
in PD as well.50 On the other hand, it will be interesting to
assess the relationship, if any, of Hb levels in blood and DA
cells in normal and pathological conditions of hematological
origin, such as thalassemia. Recent reports51,52 associate
blood Hb levels and PD, suggesting that high Hb is linked to an
increase risk of PD.
Our results support a model where Hb levels in A9 neurons
may be associated with cellular susceptibility in PD, position-
ing Hb in the list of potential PD modifiers that deserve further
attention.
Materials and Methods
Generation of stable cell line. From pBudCE4.1-β-globin-MYC-IRES-
eGFP, 2xFLAG-α-globin, as previously described,12 we generated a mutated mouse
Hb, that we called pBUD-mut β-globin-MYC-IRES-eGFP, 2xFLAG-mut α-globin. In
detail, the proximal hystidines of α- and β-chains were mutated into a glycine
(respectively, His87Gly and His92Gly). We used the QuikChange Site-Directed
Mutagenesis Kit (Stratagene, San Diego, CA, USA) according to the manufacturer’s
instructions. The list of primers used for mutagenesis is in Supplementary Table S1.
iMN9D cell line was transfected with pBUD-mut β-globin-MYC-IRES-eGFP,
2xFLAG-mut α-globin using Lipofectamine 2000 (Life Technologies, Carlsbad,
CA, USA) according to the manufacturer’s instructions. After 24 h of transfection,
cells were collected. A cell strainer with 70 μm nylon mesh (BD Falcon, Franklin
Lakes, NJ, USA) was used to obtain a single-cell suspension before sorting. 7-AAD
(Beckman-Coulter, Brea, CA, USA) was added to the cell suspension to exclude
dead cells. A high-speed cell sorter (MoFlo, Brea, CA, USA) was used to sort
subpopulation of cells expressing green fluorescent protein (GFP). Sorting
parameters used were described previously.12 After sorting, cells were re-plated,
and 48 h later, 300 μg/ml zeocyn (Life Technologies) was added for selection.
Cell cultures and treatments. We used MN9D-Nurr1Tet-on (iMN9D) cell line
stably transfected with pBUD-IRES-eGFP (that we called control cells) or with
pBUD-β-globin-MYC IRES-eGFP, 2xFLAG-α-globin (that we called Hb cells), as
previously described,12 or with pBUD-mut β-globin-MYC-IRES-eGFP, 2xFLAG-mut
α-globin (that we called mut Hb cells). Cells were maintained in culture using
DMEM/F12 medium (Life Technologies) supplemented with 10% fetal bovine serum
(Sigma-Aldrich, St. Louis, MO, USA), 100 μg/ml penicillin (Sigma-Aldrich), 100 μg/
ml streptomycin (Sigma-Aldrich), 300 μg/ml neomycin (Life Technologies) selection
and 150 μg/ml zeocyn (Life Technologies) selection at 37 °C in a humidified CO2
incubator. Nurr1 expression in iMN9D cell lines were induced by addition of 3 μg/ml
doxycycline (Sigma-Aldrich) to the culture medium every 48 h. Cells were grown as
above except that the 10% fetal bovine serum was changed to 5%.53 For
treatments, the following reagents were used: MPP+ (Sigma-Aldrich) and rotenone
(Sigma-Aldrich) for 16 h at different concentrations.
Generation and purification of recombinant AAVs. We used AAV
serotype 9 for our experiments because of its high expression level and its brain
tropism.54 The fragments corresponding to 2xFLAG-α-globin and β-globin-MYC
were cloned into the pAAV-MCS vector (Agilent Technologies, Santa Clara, CA,
USA), which was used to produce recombinant AAV vectors. In addition, we use
pAAV-MCS vector as control. AAV of serotype 9 were generated in HEK 293 T cells,
using a triple-plasmid co-transfection for packaging. Viral stocks were obtained by
CsCl2 gradient centrifugation. Titration of AAV viral particles was performed by real-
time PCR quantification of the number of viral genomes. The viral preparations had
the following titres: AAV9-2xFLAG-α-globin 7 × 1013 viral genome particles/ml,
AAV9-β-globin-MYC 8.8 × 1013 viral genome particles/ml and AAV9-control
7.5 × 1012 viral genome particles/ml.
Animals. All animal experiments were performed in accordance with European
guidelines for animal care and following Italian Board of Health permissions (DM
2/2012-B, 9 January 2012). Mice were housed and bred in SISSA animal facility,
with 12 h dark/light cycles and controlled temperature and humidity. Food and water
were provided ad libitum.
Rotarod test. To measure locomotor activity, mice were tested with a rotarod
apparatus with automatic timers and falling sensors (Crisel Instruments, Roma,
Italy) at the indicated number of weeks during the light phase of the 12 h light/12 h
dark cycle. Mice were first trained on the rotarod for 5 consecutive days. Animals
that stayed on the rod for 300 s at 5 r.p.m. during training were selected and were
randomly assigned to two groups. Mice were tested for four trials (maximum of
300 s/trial) at 5, 10, 15 and 20 r.p.m. For each trial, the time each mouse remained
on the rotating rod was recorded and the best three trials were averaged as a
measure of motor performance.
Stereotaxic surgery. The stereotaxic procedure followed were according to
Cetin et al.55 Adult (8 week old) male C57Bl/6 mice weighing 25 g± 3 g were used
for experiments. Mice were preanaesthetized with Tramadolo i.p. (30 mg/kg body
weight) and anaesthetized with a mixture of Xylazina (15 mg/kg body weight) and
Zoletil (15 mg/kg body weight) i.p. A stereotaxic injection of 3 μl of viral vector
suspension (AAV9-control or a mixture of AAV9-2xFLAG-α-globin and AAV9-β-
globin-MYC, that we called AAV9-Hb) was delivered to the left SNpc. The
coordinates were: anterior/posterior (A/P) − 3.2 mm from bregma, medio/lateral
(M/L) − 1.2 mm from bregma and dorso/ventral (D/V) − 4.5 mm from the dura. The
coordinates used were calculated according to the Franklin and Paxinos Stereotaxic
Mouse Atlas. The injection rate was 0.2 μl/30 s using a 10 μl syringe with 26 gauge
needle (SGE, Ringwood, VIC, Australia).
Tissue collection and processing. At the indicated number of weeks after
injection of AAVs into SNpc, the animals were killed. Following induction of deep
anaesthesia with an overdose of a mixture of Xylazina and Zoletil, the animals were
intensively perfused transcardially with PBS 1 × . For biochemical analysis, SN,
striatum and CTX were dissected and immediately frozen in liquid nitrogen and
stored at − 80 °C, pending analyses. For immunohistochemical analysis, after the
intensively transcardially perfusion with PBS 1 × , animals were perfused with 4%
paraformaldehyde diluted in PBS 1 × . Brains were immediately dissected with the
Mouse Brain Matrix instrument (Protech International Inc., San Antonio, TX, USA)
and separated into two pieces, the anterior part containing the striatum and the
posterior one containing SN. Brains were postfixed in 4% paraformaldehyde for 1 h
at 4 °C. The regions containing the striatum and SN were cut in 40 μm free-floating
slides with a vibratome (Vibratome Series 1000 Sectioning System, Technical
Products International, St. Louis, MO, USA). Four consecutive series were collected
in order to represent the whole area of interest.
PCR and quantitative RT-PCR (qRT-PCR). Total RNA was extracted
from cell and mouse tissue samples using the TRIzol reagent (Life Technologies)
following the manufacturer’s instructions. Mouse tissues were homogenized using a
glass-Teflon (Thermo Scientific, Waltham, MA, USA). A fraction of the total RNA
samples were subjected to DNase I treatment (Life Technologies) at 37 °C for 1 h
and the sample was then purified on RNAeasy mini kit columns (Qiagen, Hilden,
Germany). The final quality of RNA sample was tested on agarose gel. Single-
strand cDNA was obtained from 1 μg of purified RNA using the iSCRIPT cDNA
Synthesis Kit (Bio-Rad, Hercules, CA, USA) according to the manufacturer’s
instructions. To amplify transcripts, Ex Taq DNA polymerase (Takara Bio Inc.,
Kasatsu, Japan) was used. qRT-PCR was performed in triplicate using SYBER-
Green PCR Master Mix (Bio-Rad) and an iCycler IQ Real Time PCR System (Bio-
Rad). Relative gene expression was calculated with ΔΔCt method. The complete
list of primers used for PCR and RT-qPCR is in Supplementary Table S1. All
amplicons were sequenced.
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Western blotting. Proteins derived from adherent and floating cells were
collected, washed intensely with PBS 1 × and lysed in SDS sample buffer
2 × . Proteins derived from mouse tissue were obtained using TRIzol reagent
(Life Technologies) following the manufacturer’s instructions. Proteins were
separated in 10–17% SDS polyacrylamide gel as needed. After the separation
on gel, proteins were transferred to nitrocellulose membrane (GE Healthcare Life
Science, Buckinghamshire, UK). Membrane was blocked with 5% nonfat milk in
TBST solution (TBS and 0.1% Tween20) and then incubated with primary
antibodies overnight at 4 °C or at room temperature for 2 h. The following antibodies
were used: anti-Caspase-3 1:1000 (Cell Signaling, Danvers, MA, USA), anti-cleaved
Caspase-3 1:1000 (Cell Signaling), anti-FLAG 1:2000 (Sigma-Aldrich), anti-MYC
1:2000 (Cell Signaling), anti-β-actin 1:10000 (Sigma-Aldrich), anti-TH 1:1000
(Sigma-Aldrich), anti-UBF 1:1000 (Santa Cruz, Dallas, TX, USA), anti-H3K4me3
1:5000 (Millipore, Billerica, MA, USA), anti-H3K9me2 1:5000 (Abcam, Cambridge,
UK), anti-H3 1:10000 (Cell Signaling), anti-α-tubulin 1:100 (purified from immunized
rabbits), P-4E-BP1 1:1000 (Cell Signaling), 4E-BP1 1:1000 (Cell Signaling), anti-
LC3b 1:1000 (Cell Signaling), anti-Hemoglobin 1:1000 (MP Biomedicals, Santa Ana,
CA, USA) and anti-GFP 1:1000 (Life Technologies). For development, secondary
antibodies conjugated with horseradish peroxidase (Dako, Glostrup, Denmark) were
used in combination with ECL reagent (GE Healthcare Life Science). Image
acquisition was performed using the Alliance 4.7 software (UVITEC, Cambridge,
UK). Quantification of protein bands from western blotting scans was performed with
the ImageJ Software (National Institute of Health, Bethesda, MD, USA).
Coimmunoprecipitation. Cells were lysed in immunoprecipitation buffer
(300 mM NaCl, 50 mM Tris pH 7.5, 1% Nonidet P-40, 10% glycerol), supplemented
with protease inhibitor mixture (Roche Diagnostics, Basel, Switzerland) for 30 min at
4 °C. Lysates were cleared at 15 000 × g for 20 min. Cell lysates were incubated
with anti-FLAG agarose beads (Sigma-Aldrich). After washing, immunoprecipitated
proteins were eluted with SDS sample buffer 2 × , boiled and analyzed by western
blotting.
Cellular fractionation. Nucleo-cytoplasmic separation was performed using
the Nucleo-Cytoplasmic Separation Kit (Norgen Biotek Corp., Thorold, ON, Canada)
according to the manufacturer’s instruction. The effectiveness of cellular separation
was controlled with cytoplasmic and nuclear markers TH and UBF, respectively.
Detergent-solubility fractionation. Detergent solubility was performed as
previously described.56 In detail, cells were harvested in buffer containing 50 mM
Tris-HCl pH 7.4, 175 mM NaCl, 5 mM EDTA pH 8.0 supplemented with protease
inhibitor mixture (Roche Diagnostics). Cells were lysed once through a 30 gauge
needle and sonicated for 10 s. After the addition of Triton X-100 (final concentration
1%), lysates were incubated for 30 min on ice and centrifugated at 15 000 × g for
1 h at 4 °C in order to separate the Triton X-100 soluble (supernatant) and insoluble
(pellet) fractions. The pellet was dissolved in 2% SDS-containing lysis buffer and
sonicated for 10 s. The effectiveness of cellular separation was controlled with
α-tubulin, a marker of the soluble fraction.
Fluorescence-activated cell sorter analysis. For FACS analysis, both
adherent and floating cells were collected and fixed in ice-cold 70% ethanol. After
rehydration, cells were suspended in PBS+0.1% NP40+200 μg/ml RNaseA and
treated with 40 μg/ml propidium iodide and analyzed on a flow cytometer
(FACSCalibur, BD Biosciences, Franklin Lakes, NJ, USA). At least 104 GFP-positive
cells were analysed in each acquisition. FACS data were processed using the
FlowJo software (Tree Star Inc., Ashland, OR, USA) and cell cycle profiles were
determined using the Watson pragmatic mode.
WST-1 analysis. Cell viability was assayed using WST-1 reagent (Roche
Diagnostics), according to the manufacturer’s protocol. In detail, absorbance was
measured on a microplate ELISA reader (Thermo Scientific) at a 450 and 620 nm
detection wavelength. Normalized WST was calculated as follows: WST
(%)= ((A450nm–A620 nm of treated sample− A450 nm–A620 nm of blanck)/(A450 nm–
A620 nm of untreated sample−A450nm–A620nm of blanck)) × 100. Blank represents
wells containing culture medium only.
Immunocytochemistry. Cells were fixed in 4% paraformaldehyde for 10 min,
then washed with PBS 1 × , treated with 0.1 M glycine for 4 min in PBS 1 × and
permeabilized with 0.1% Triton X-100 in PBS 1 × for 4 min. After washing with PBS
1 × and blocking with 0.2% BSA, 1% NGS, 0.1% Triton X-100 in PBS 1 × , cells
were incubated with primary antibodies diluted in blocking solution for 90 min at
room temperature. After washes in PBS 1 × , cells were incubated with labelled
secondary antibodies for 60 min. For nuclear staining, cells were incubated with
1 μg/ml DAPI for 5 min. Cells were washed and mounted with Vectashield mounting
medium (Vector Laboratories, Burlingame, CA, USA). The following antibodies were
used: anti-FLAG 1:1000 (Sigma-Aldrich), anti-MYC 1:2000 (Cell Signaling) and anti-
NPM 1:100 (Invitrogen, Carlsbad, CA, USA). For detection, Alexa Fluor-488, -594 or
-405 (Life Technologies) antibodies were used. To detect insoluble Hb,
immunocytochemistry was performed as previously described.42 All images were
collected using confocal microscopes (LEICA TCS SP2, Wetzlar, Germany and
Nikon D-Eclipse C1, Tokyo, Japan). Using the Volocity 3D Image Analysis Software
(PerkinElmer, Waltham, MA, USA), aggregates per cell were counted. Values were
represented as percentage of the total.
LysoTracker staining. Cells were stained without fixation with 50 nM
LysoTracker Red (Molecular Probes, Eugene, OR, USA) in growth medium for
1 h. Stained cells were immediately fixed with 4% paraformaldeide and follow a
standard immunofluorescence protocol. LysoTracker staining were visualized with a
confocal microscope (Nikon D-Eclipse C1). Using Volocity 3D Image Analysis
Software (PerkinElmer), autophagosomes per cell were counted. Autophagy activity
was defined as follows:57 high: 410 autophagosomes/cell; medium: 6–10
autophagosomes/cell; and low:o6 autophagosomes/cell. Values were represented
as percentage of the total.
Immunohistochemistry. For immunohistochemistry, a standard avidin–biotin
ABC procedure was performed on free-floating slides. Endogenous peroxidase
activity was first quenched by a 10 min incubation in 10% methanol with 3%
hydrogen peroxide in PBS 1 × , followed by incubation in 10% NGS, 1% BSA and
1% Fish gelatin in PBS 1 × for 1 h. The primary and secondary antibodies were
diluted in 1% BSA, 0.3% Triton X-100 and 0.1% Fish gelatin in PBS 1 × . Incubation
with primary antibodies 1:1000 anti-TH (Sigma-Aldrich) was performed overnight at
RT. Incubation with 1:200 biotinylated secondary antibody (Santa Cruz) was
performed for 1 h at RT, followed by 1 h incubation in avidin–biotin–peroxidase
solution (ABC Kit, Vector Laboratories). The staining was visualized using 3,3′-
diaminobenzidine (Sigma-Aldrich) as a chromogen for 2 min. The sections were
then mounted on slides (Thermo Scientific SuperFrost Plus), dehydrated in
ascending alcohol concentrations, cleared in xylene and mounted with Eukitt
mounting medium (O. Kindler GmbH, Freiburg, Germany). All images were collected
in bright-field (LEICA DM6000).
For fluorescent immunohistochemistry, free-floating slides were treated with 0.1 M
glycine for 5 min in PBS 1 × and then with 1% SDS in PBS 1 × for 1 min at RT. Slides
were blocked with 10% NGS, 1% BSA and 1% Fish gelatin in PBS 1 × for 1 h at RT.
The antibodies were diluted in 1% BSA, 0.3% Triton X-100 and 0.1% Fish gelatin in
PBS 1 × . For double immunoflurescence, incubation with primary antibodies was
performed overnight at RT and incubation with 1:500 Alexa fluor-conjugated
secondary antibodies (Life Technologie) was performed for 2 h at RT. Nuclei were
labelled with 1 μg/ml DAPI. For triple immunofluorescence, incubation with primary
antibodies was performed overnight at RT, incubation with 1:500 Alexa fluor-
conjugated secondary antibodies (Life Technologies) and 1:100 biotin-labelled
secondary antibody (Sigma-Aldrich) was performed for 2 h at RT, followed by 1 h
incubation in 1:100 streptavidin, Marina Blue conjugate (Life Technologies). Slides
were mounted with mounting medium for fluorescence Vectashield (Vector
Laboratories). The following primary antibodies were used: anti-TH 1:1000 (Sigma-
Aldrich or Millipore), anti-FLAG 1:100 (Sigma-Aldrich), anti-MYC 1:100 (Cell
Signaling) and anti-Hemoglobin 1:1000 (MP Biomedicals). For detection, Alexa fluor-
488 or -594 (Life Technologies) were used. All images were collected using confocal
microscopes (LEICA TCS SP2).
Dopamine determination by HPLC. Cells were lysed in 200 μl of 0.1 M
perchloric acid, sonicated and spun in a microcentrifuge at 10 000 × g for 10 min at
4 °C. The supernatant was transferred in ultra-free microcentrifuge tubes (Millipore)
and spun at 10 000 × g for 5 min at 4 °C. Samples (11 μl) were injected into the
HPLC apparatus. Measurements of dopamine were made by HPLC with an
electrochemical detection system (ALEXYS LC-EC, Antec Leyden BV, Zoeter-
woude, The Netherlands) equipped with a reverse-phase column (3-μm particles,
ALB-215 C18, 1 × 150 mm, Antec Leyden BV) at a flow rate of 50 μl/min and
electrochemically detected by a 0.7 mm glass carbon electrode (VT-03, Antec
Leyden BV). The mobile phase contained 50 mM H3PO4, 50 mM citric acid, 8 mM
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KCl, 0.1 mM EDTA, 400 mg/l octanesulfonic acid sodium salt and 8% (vol/vol)
acetonitrile (pH 3.0).
Determination of striatal DA density. DA innervation in the striatum was
estimated via optical density (OD) determination of immunostaining using Leica
DM6000 microscope. Briefly, striatal sections were immunostained with anti-TH
antibody. Scans of three different section were acquired corresponding to the rostral,
intermediate and caudal portion of the striatum. Using the ImageJ Software
(National Institute of Health), the region of interest on the section was outlined and
the mean OD value for the region was determined. A background value,
corresponding to a region devoid of immunoreactivity (i.e., corpus callosum), was
subtracted from each determination. The OD values were calculated as arbitrary
units and were expressed as a percentage relative to the contralateral side of
control-injected mice.
Quantification of DA neurons in the SNpc. One out of the four series of
40 μm freefloating slides were immunostained with anti-TH antibody. SNpc was
outlined under a low magnification objective (×4) following landmarks from the
Franklin and Paxinos Mouse Atlas and was analyzed under a × 100 objective of an
Olympus BH2 microscope (Tokyo, Japan). Cells were counted throughout the whole
SNpc area and through the entire section thickness. Quantification of TH+ cells was
performed according to a stereological approach using the Olympus CAST-Grid
system (Olympus Denmark A/S, Albertslund, Denmark). TH+ cells were counted by
a systematically random sampling scheme using approximately 160 × 160 μm2
optical dissectors. All counts were performed blind to the experimental status of the
animals. The orientation for each brain was determined by marking one side of each
brain by performing an incision through the contralateral side of the brain. The TH+
cell values were expressed relative to the contralateral side of control-injected mice.
Statistical analysis. All data were obtained by at least three independent
experiments. Data represent the mean± S.D.; each group was compared
individually with the reference control group using Student’s t-test (Microsoft Excel
software, Microsoft, Redmond, WA, USA). Where appropriate, P-values were
adjusted for multiple testing using the Benjamini–Hochberg procedure to control the
false discovery rate. Statistical significance differences to reference samples were
indicated. Regarding statistical analysis of in vivo experiments, data represent the
mean±S.E.M. Each group and side differences were analysed by one-way ANOVA
test using the STATVIEW software (Abacus Concepts, Berkeley, CA, USA).
Significance was set at Po0.05.
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